Kumar Amanika, Langstraat Carrie L, DeJong Stephanie R, McGree Michaela E, Bakkum-Gamez Jamie N, Weaver Amy L, LeBrasseur Nathan K, Cliby William A
Division of Gynecologic Surgery, Mayo Clinic, Rochester, MN, United States.
Division of Gynecologic Surgery, Mayo Clinic, Rochester, MN, United States.
Gynecol Oncol. 2017 Oct;147(1):104-109. doi: 10.1016/j.ygyno.2017.07.126. Epub 2017 Jul 19.
To assess the impact of frailty as measured by a frailty deficit index (FI) on outcomes in advanced epithelial ovarian cancer (EOC) after primary debulking surgery (PDS).
Women with Stage IIIC/IV EOC who underwent PDS between 1/1/2003-12/31/2011 were included. Medical records were reviewed for patient characteristics and outcomes. The FI includes 30 items scored at 0, 0.5 or 1 and is calculated by summing across all the item scores and dividing by the total. Frailty was defined as a FI ≥0.15. Associations were assessed using logistic regression and Cox proportional hazards regression.
Of the 535 studied, 78% had stage IIIC disease and mean (SD) age was 64.3 (11.3) years. Median FI was 0.08, and 131 patients (24.5%) were considered frail with FI ≥0.15. Compared to non-frail patients, frail patients were more likely to have an Accordion grade 3+ complication (28.2 vs. 18.8%; odds ratio (OR): 1.70, 95% CI: 1.08-2.68) and more likely to die within 90days of surgery (16.0 vs. 5.2%; OR: 3.48, 95% CI: 1.83-6.61). After adjusting for known risk factors, these associations remained significant, adjusted OR (aOR): 1.62, 95% CI: 1.00-2.62; aOR: 2.60, 95% CI 1.32-5.10; and aOR: 0.57, 95% CI 0.34-0.97, respectively. Overall survival (OS) for the entire cohort was 39.6months (m). OS was shorter in the frail versus non-frail (median 26.5 vs 44.9m, p<0.001). Frailty was independently associated with death (adjusted hazard ratio: 1.52, 95% CI: 1.21-1.92) after adjusting for known risk factors.
Frailty is a common finding in patients with EOC and is independently associated with worse surgical outcomes and poorer OS. Routine assessments of frailty can be incorporated into patient counseling and decision-making for the EOC patient beyond simple reliance on single factors such as age.
评估通过虚弱缺陷指数(FI)衡量的虚弱对晚期上皮性卵巢癌(EOC)患者初次肿瘤细胞减灭术(PDS)后结局的影响。
纳入2003年1月1日至2011年12月31日期间接受PDS的IIIC/IV期EOC女性患者。回顾病历以获取患者特征和结局信息。FI包括30项,每项得分0、0.5或1,通过将所有项目得分相加并除以总分来计算。虚弱定义为FI≥0.15。使用逻辑回归和Cox比例风险回归评估相关性。
在535例研究对象中,78%患有IIIC期疾病,平均(标准差)年龄为64.3(11.3)岁。FI中位数为0.08,131例患者(24.5%)被认为虚弱(FI≥0.15)。与非虚弱患者相比,虚弱患者更有可能发生3级及以上手风琴式并发症(28.2%对18.8%;优势比(OR):1.70,95%置信区间(CI):1.08 - 2.68),且更有可能在术后90天内死亡(16.0%对5.2%;OR:3.48,95%CI:1.83 - 6.61)。在调整已知风险因素后,这些相关性仍然显著,调整后OR(aOR)分别为:1.62,95%CI:1.00 - 2.62;aOR:2.60,95%CI 1.32 - 5.10;aOR:0.57,95%CI 0.34 - 0.97。整个队列的总生存期(OS)为39.6个月(m)。虚弱患者的OS较非虚弱患者短(中位数26.5对44.9m,p<0.001)。在调整已知风险因素后,虚弱与死亡独立相关(调整后风险比:1.52,95%CI:1.21 - 1.92)。
虚弱在EOC患者中很常见,并且与更差的手术结局和更差的OS独立相关。除了单纯依赖年龄等单一因素外,虚弱的常规评估可纳入EOC患者的咨询和决策过程中。